Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

TransMedics (TMDX) Consolidated Net Income (2018 - 2025)

Historic Consolidated Net Income for TransMedics (TMDX) over the last 8 years, with Q3 2025 value amounting to $24.3 million.

  • TransMedics' Consolidated Net Income rose 47711.1% to $24.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $91.8 million, marking a year-over-year increase of 18436.68%. This contributed to the annual value of $35.5 million for FY2024, which is 23964.95% up from last year.
  • Per TransMedics' latest filing, its Consolidated Net Income stood at $24.3 million for Q3 2025, which was up 47711.1% from $34.9 million recorded in Q2 2025.
  • Over the past 5 years, TransMedics' Consolidated Net Income peaked at $34.9 million during Q2 2025, and registered a low of -$25.4 million during Q3 2023.
  • In the last 5 years, TransMedics' Consolidated Net Income had a median value of -$2.6 million in 2023 and averaged $744263.2.
  • Its Consolidated Net Income has fluctuated over the past 5 years, first crashed by 24233.77% in 2023, then soared by 131818.18% in 2024.
  • Quarter analysis of 5 years shows TransMedics' Consolidated Net Income stood at -$12.8 million in 2021, then soared by 45.58% to -$7.0 million in 2022, then surged by 152.56% to $3.7 million in 2023, then skyrocketed by 87.58% to $6.9 million in 2024, then skyrocketed by 254.01% to $24.3 million in 2025.
  • Its Consolidated Net Income stands at $24.3 million for Q3 2025, versus $34.9 million for Q2 2025 and $25.7 million for Q1 2025.